Physician profile
Scott Orr
NPI 1326380684
$16,379.16
in general payments reported to CMS, 2019-2025
19 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $40.01 · 2021: $225 · 2022: $384 · 2023: $828 · 2024: $15K · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $4,050 · Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,200.00 |
| Travel and Lodging | $4,050.18 |
| Food and Beverage | $1,369.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $11,274.78 | 2021-2024 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $3,603.75 | 2022-2024 | Arcos, Persona, Mymobility Platform |
| Pacira Pharmaceuticals Incorporated | $629.75 | 2021-2023 | Iovera, Zilretta, Exparel |
| Ethicon US, LLC | $148.65 | 2024-2025 | Vistaseal, Dermabond Prineo, Stratafix |
| Djo, LLC | $100.93 | 2023 | Donjoy |
| Dynasplint Systems INC. | $95.53 | 2021 | |
| Aesculap Implant Systems, LLC | $79.13 | 2019 | |
| Orthalign INC | $70.46 | 2025 | Orthalign Plus |
| Abbott Laboratories | $63.43 | 2021-2024 | Proclaim |
| Depuy Synthes Sales INC. | $55.68 | 2021-2022 | |
| Bioventus LLC | $47.75 | 2021-2023 | L360 Thigh System |
| Smith+Nephew, INC. | $40.15 | 2023-2024 | Ferkel |
| Pacira Therapeutics, INC. | $37.40 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $31.04 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $29.40 | 2023 | Seglentis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $24.45 | 2020 | |
| Stryker Corporation | $17.43 | 2024 | T2 |
| Endo Pharmaceuticals INC. | $15.56 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.